Higher ACE counts were significantly associated with greater symptom burden during anti-estrogen therapy in patients with stage I to IV breast cancer in the Appalachian region of Tennessee.
A. Khan
Advertisement
Articles by A. Khan
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Radiation Oncology Trials You May Have Missed at ASCO 2026
2
Navigating the RCC Adjuvant Landscape: Examining the Phase 3 RAMPART Trial
3
Durvalumab Shows Similar Outcomes Across NSCLC PD-L1 Expression Groups
4
Menin Inhibition Shows Utility in Heterogenous AML Population
5